Long
Sell off levels out on FSD
FSD Pharma and it's subsidiaries have progress in advancing their three drug candidates (PEA, Lycid Psych. & Lucid-MS) through clinical phases. After partnering with covar pharmaceuticals and Acquiring Lucid Psycheceuticals (subsidiary of FSD pharma Inc.), HUGE was able to recently purchase a new facility in Cobourg Ontario (CAD $17 million) which will be closing of May 31st. Should be a break soon to come after sell off.
Note
Sale finalized of Cobourg FacilityNote
As we near phase one of Clinicals we are seeing improvement, and by that I mean a stop in the sell of momentum we've been seeing in this security for quite some time.Stock price has been consistent in a sideways channel for the majority of the year .
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.